ARCHIVES

In Brief: Kalt Named Director, NCI extramural Div.; Browning Is Deputy; Other DEA Staff Changes

This article is from The Cancer Letter archive.

Vol. 20 No. 23 | June 10, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010

Clinical Trials Approved By NCI’s CTEP Listed

February 25, 2005

Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds

July 3, 1992

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

NCI-Approved CTEP Trials For the Month of October

October 26, 2012

Varmus: NCI Faces “Budgetary Disaster;” Flat Funds, Cuts Loom For Most Programs

January 14, 2011